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Abstract The ligand binding domains of the human miner-
alocorticoid receptor (hMR) and glucocorticoid receptor (hGR)
display a high sequence homology. Aldosterone and cortisol, the
major mineralocorticoid and glucocorticoid hormones, are very
closely related, leading to the cross-binding of these hormones to
both receptors. The present study reports on the mechanism by
which hMR and hGR are activated preferentially by their
cognate hormones. We found that the ability of corticosteroids to
stimulate the receptor’s transactivation function is depending on
the stability of the steroid-receptor complexes. In the light of a
hMR structural model we propose that contacts through the
corticosteroid C21 hydroxyl group are sufficient to stabilize
hMR but not hGR and that additional contacts through the C11-
and C17-hydroxyl groups are required for hGR.
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1. Introduction
The major human mineralocorticoid and glucocorticoid
hormones, aldosterone and cortisol, are structurally very sim-
ilar. They act by binding to their cognate receptors, the min-
eralocorticoid receptor (MR) and glucocorticoid receptor
(GR) [1]. MR and GR belong to a large family of ligand-
activated transcription factors that are structurally and func-
tionally related [2,3]. They are characterized by a conserved
DNA binding domain and a C-terminal ligand binding do-
main (LBD) essential for chaperone protein interaction,
dimerization and hormone-dependent transactivation.
The way in which aldosterone acts through its own receptor
has been a puzzle for some time for two main reasons. Aldos-
terone and cortisol both bind to the human MR (hMR) with
the same a⁄nity, and the plasma glucocorticoid concentration
is 100^1000-fold higher than that of aldosterone. Conse-
quently, most of the hMR should be occupied by glucocorti-
coids, resulting in a sodium retention. The role of the 11L-
hydroxysteroid dehydrogenase type 2 (11LHSD2) in minera-
locorticoid/glucocorticoid selectivity has been established dur-
ing the past decade [4,5]. This enzyme metabolizes 11L-hy-
droxylated glucocorticoids, but not aldosterone, into 11-keto
derivatives with a low a⁄nity for the MR [6]. Receptor-asso-
ciated mechanisms might also contribute to aldosterone selec-
tivity, especially in aldosterone-sensitive tissues where
11LHSD2 and MR are not coexpressed [7].
Studies of a hMR-LBD homology model and mutagenesis
analysis have identi¢ed several residues involved in the inter-
action with the functional groups common to aldosterone and
cortisol [8]. The Gln-776 and Arg-817 residues interact with
the 3-keto group and Asn-770 with the 21 hydroxyl function.
Aldosterone and cortisol di¡er at positions C11, C17 and
C18. Aldosterone has a 11^18 hemiketal bridge and cortisol
has C11L and C17K hydroxyl groups. Despite these di¡eren-
ces, aldosterone and cortisol display similar a⁄nity for MR.
Nevertheless MR is more sensitive to aldosterone than to
cortisol [9^12], an observation that is not 11LHSD-dependent
[12]. Conversely, cortisol better stimulates the GR transacti-
vation than aldosterone, although these two hormones bind to
the hGR with an a⁄nity of the same order of magnitude
[9,11].
This study was therefore carried out to explore the mecha-
nism of hormonal recognition by each class of corticosteroid
receptors. The stability of hMR and hGR associated with
aldosterone, cortisol or dexamethasone, a synthetic glucocor-
ticoid, was examined together with the ligand-induced hMR
and hGR conformation changes. The receptors transactiva-
tion activity in response to corticosteroids bearing hydroxyl
groups at C11, C17 and/or C18 position was measured by
cotransfection assays. The ability of hMR and hGR to be
selectively activated by their cognate hormones is due to spe-
ci¢c steroid receptor contacts that stabilize the active receptor
conformation.
2. Materials and methods
2.1. Chemicals
[1,2-3H]Aldosterone (40^60 Ci/mmol), [1,2,6,7-3H]cortisol (63 Ci/
mmol), [1,2,4-3H]dexamethasone (42 Ci/mmol) and 35S-methionine
were purchased from Amersham (Les Ulis, France). Non-radioactive
aldosterone (Aldo), corticosterone (B), 11-deoxycorticosterone
(DOC), cortisol (F), 11-deoxycortisol (cortexolone, S), dexamethasone
(Dex), chymotrypsin and trypsin were obtained from Sigma (St.
Louis, MO, USA). 18-hydroxycortisol (18OHF) and 18-oxocortisol
(18oxoF) were synthesized as previously described [13,14]. The struc-
ture of the steroids used are shown in Fig. 1. Entensify Universal
Autoradiography Enhancer was obtained from Du Pont-New Eng-
land Nuclear (Boston, MA, USA). Products for cell culture were
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from Gibco-BRL (Cergy Pontoise, France). The profection mamma-
lian transfection system and the TNT T7-Quick coupled transcription/
translation system were obtained from Promega (Charbonnie'res,
France). Steroid solutions were prepared in ethanol, dried and sus-
pended in 50% (v/v) polyethylene glycol 300 prepared in TEG (20 mM
Tris^HCl, 1 mM EDTA and 10% glycerol, pH 7.4 at 20‡C) to give a
5% (v/v) ¢nal concentration of polyethylene glycol 300 in the lysate.
2.2. Construction of expression plasmids
The plasmid pchGR was constructed by excising a KpnI^XhoI frag-
ment including the entire hGRK coding sequence and about 110 bp
and 500 bp of the 5P and 3P untranslated regions from the plasmid
pRShGRK [15] and inserting it into pcDNA3 (Invitrogen NV, Leek,
The Netherlands).
2.3. Cell culture and transfection
COS-7 cells were cultured in six-well trays in the presence of Dul-
becco’s minimal essential medium (DMEM, Gibco-BRL, Cergy Pon-
toise, France) supplemented with 10% heat-inactivated fetal calf se-
rum (FCS), 2 mM glutamine, 100 IU/ml penicillin and 100 Wg/ml
streptomycin in a humidi¢ed atmosphere with 5% CO2. Cells were
maintained in the medium supplemented with 10% charcoal-stripped
FCS 4 h before and throughout the transfection procedure. Cells were
transfected by the phosphate calcium precipitation method (Promega
system). The phosphate solution, prepared for six-well trays, contains
5 Wg of one of the receptor expression vectors pchMR [8] or pchGR,
10 Wg of pFC31Luc that contains the MMTV promoter driving the
luciferase gene [16] and 5 Wg of pSVL including the gene encoding
L-galactosidase. The steroids to be tested were added to the cells 12 h
after transfection and incubation continued for 24 h. Cell extracts
were then prepared and assayed for luciferase [17] and L-galactosidase
activities [18]. Transfection e⁄ciency was standardized by dividing the
relative light units obtained in the luciferase assay by the optical
density obtained in the L-galactosidase assay.
2.4. Steroid binding at equilibrium
The hMR or hGR were expressed in vitro using the T7-coupled
rabbit reticulocyte lysate system and the lysate was diluted two-fold
with ice-cold TEGWD bu¡er (20 mM sodium tungstate and 1 mM
dithiothreitol in TEG). It was then incubated for 4 h at 4‡C with
various concentrations of [3H]steroid (0.1 to 100 nM). Bound (B)
and free (F) steroids were separated using dextran-charcoal as previ-
ously described [8]. The change in B as a function of F was analyzed
[19] and the dissociation constant at equilibrium, Kd, was calculated.
2.5. Kinetic experiments
The hMR or hGR was translated and the lysate was diluted two-
fold with ice-cold TEGWD bu¡er and then incubated with 10 nM
[3H]steroid for 1 h at 20‡C. One half of the labelled lysate was kept at
20‡C to measure the stability of the [3H]steroid^MR complexes, and
the other was incubated with 10 WM of unlabeled steroid for various
periods. Bound and free steroids were separated with dextran-char-
coal. Parallel incubations containing [3H]steroid plus a 1000-fold ex-
cess of unlabeled steroids were used to calculate the non-speci¢c bind-
ing. The half-lives of the steroid-receptor complexes (t1=2) were
calculated from the equation Bt = B0 e3k31t, where B0 and Bt
are the speci¢c steroid binding at times 0 and t of the dissociation
period. Bt is corrected for the stability of steroid binding at each
dissociation time.
2.6. Limited proteolytic digestion of translated receptors
[35S]Receptor synthesized in vitro were incubated with or without
unlabeled steroid (10310 to 1035 M) for 10 min at 20‡C. Chymotryp-
sin (100 Wg/ml) was added to [35S]-hMR and trypsin (60 Wg/ml) to
[35S]-hGR. Aliquots of digestion products (1 Wl) were mixed with 20 Wl
protein loading bu¡er, boiled for 5 min, loaded onto a 12.5% SDS-
polyacrylamide gel and electrophoresed. The gels were ¢xed for 30
min in methanol/acetic acid/distilled water (30:10:60), treated with
Entensify, dried and autoradiographed at -80‡C overnight. Autoradio-
graphs were scanned by image analysis (Optilab, Graftek, France).
Results are given as optical density, expressed in arbitrary units.
3. Results
3.1. Corticosteroids di¡erently protect hMR and hGR against
proteolysis
It has been shown that limited chymotrypsin digestion of
hMR generates a major 30 kDa fragment whose resistance to
chymotrypsin is increased by aldosterone binding, indicating a
change in the receptor compaction [20,21]. To examine the
in£uence of the steroid on the 30 kDa fragment resistance,
hMR was incubated with aldosterone, cortisol or dexametha-
sone (10310^1035 M) and then treated with 100 Wg/ml chymo-
trypsin for 10 min at 20‡C. Under these conditions the ligand-
free hMR was completely digested by chymotrypsin (data not
shown), but incubation with steroids increased the fraction of
undigested 30 kDa fragment in a dose-dependent manner
(Fig. 2). Aldosterone protected the hMR 30 kDa fragment
against proteolysis better than did glucocorticoids: 8U1039
M aldosterone and 5U1038 M of cortisol were required to
recover 50% of the undigested fragment, whereas 1035 M
dexamethasone did not fully protect the hMR. Digestion of
hGR with trypsin generates 27 and 30 kDa fragments whose
respective abundance depends upon the incubation time and
trypsin concentration [22,23]. Incubation of the ligand-free
hGR with 60 Wg/ml trypsin for 10 min at 20‡C led to a com-
plete digestion (data not shown). Incubation of hGR with
steroids before trypsin treatment led to a 27 kDa fragment
whose intensity is depending upon the steroid concentration:
5U1039 M dexamethasone and 8U1037 M cortisol were re-
quired to recover 50% of the undigested fragment, whereas
1035 M aldosterone did not fully protect the hGR, indicating
Fig. 1. Natural and synthetic corticosteroids.
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a low e⁄ciency of aldosterone in protecting hGR against pro-
teolysis (Fig. 2).
3.2. hMR and hGR are di¡erently stabilized by corticosteroids
The dissociation constants at equilibrium (Kd) of steroids
for in vitro expressed hMR or hGR were measured from
Scatchard plots and the half-life times of steroid-receptor
complexes were calculated from dissociation kinetics studies.
Aldosterone, cortisol and dexamethasone have similar a⁄nity
for the hMR (Kd : 0.5^0.8 nM, Table 1). Aldosterone dissoci-
ated much more slowly from the hMR than did cortisol or
dexamethasone, indicating that the aldosterone-hMR com-
plexes were more stable than the glucocorticoid-hMR com-
plexes (Fig. 3 and Table 1). Dexamethasone bound to hGR
with an a⁄nity higher (Kd : 3.7 nM) than cortisol or aldoster-
one (Kd : 11^14 nM). There were also di¡erences in the o¡-
rates since aldosterone and cortisol dissociated much more
rapidly from the hGR than did dexamethasone (Fig. 3 and
Table 1). Thus, the order of potency of the steroids for sta-
bilizing the steroid-hMR complexes (AldosFsDex) is op-
posite to that observed for the hGR (Dexs 036:004sFsAl-
do).
3.3. Speci¢c corticosteroid hydroxyl groups determine hMR
and hGR activities
Aldosterone, cortisol and DOC have two carboxyl groups
in common at C3 and C20 and a hydroxyl group at C21.
DOC is devoid of any other substituent, aldosterone has a
11^18 hemiketal bridge and cortisol has C11L and C17K hy-
droxyl groups (Fig. 1). The hMR and hGR transactivation
functions in response to natural or synthetic steroids bearing a
hydroxyl group at C11, C17 and/or C18 were measured. At
1039 M DOC maximally stimulated hMR transactivation, but
hMR was less sensitive to DOC (ED50 : 2U10310 M) than to
aldosterone (ED50 : 8U10311 M) (Fig. 4). The presence of a
11L-hydroxyl group (corticosterone, B), or a 17K-hydroxyl
group (cortexolone, S), or 11L- and 17K-hydroxyl groups (cor-
tisol, F) led to a decrease of the steroid ability to stimulate
hMR transactivation (ED50 : 5U1039^1037 M). Dexametha-
sone with 11L-, 17K- and 21-hydroxyl groups, stimulated
hMR transactivation with an ED50 of 2U1038 M (Fig. 4).
The e¡ect of C18-hydroxylation on the mineralocorticoid ac-
tivity was examined by testing the ability of 18-hydroxycorti-
sol (18OHF) and 18-oxocortisol (18oxoF), two natural corti-
costeroids whose urinary excretion is increased during
primary aldosteronism [24]. The hMR transactivation activity
was very low in the presence of 18OHF, even when the steroid
concentration was high. In contrast, 18oxoF was almost as
potent as DOC in stimulating hMR transactivation (ED50 :
2U10310 M).
Dexamethasone was the best stimulator of hGR transacti-
Fig. 2. E¡ect of corticosteroids on hMR and hGR proteolysis. 35S-
labeled hMR or hGR were produced by translation in vitro and in-
cubated with of unlabeled steroid (10310^1035 M). Steroid-hMR
complexes were treated with 100 Wg/ml chymotrypsin and steroid-
hGR complexes with 60 Wg/ml trypsin for 30 min at 20‡C. The di-
gestion products were analyzed by electrophoresis in a 12.5% (w/v)
polyacrylamide gel and autoradiographed. The bands corresponding
to the hMR 30 kDa fragment and hGR 27 kDa fragment were
scanned and quanti¢ed. The intensities of the proteolysis fragments
recovered from each receptor are expressed as a function of steroid
concentrations, taking the maximum intensity recovered for each re-
ceptor as 100%.
Table 1
Corticosteroid binding to hMR and hGR
hMR hGR
Kd (nM) t1=2 (min) Kd (nM) t1=2 (min)
Aldosterone 0.52 þ 0.03 140 14.4 þ 2.1 5
Cortisol 0.49 þ 0.02 45 11.7 þ 0.8 5
Dexamethasone 0.73 þ 0.24 7 3.7 þ 0.6 100
hMR and hGR were synthesized in rabbit reticulocyte lysate. The lysate was diluted two-fold with TEGWD bu¡er and incubated with
[3H]steroid for 4 h at 4‡C. Bound and free steroids were separated with dextran-charcoal and the dissociation constant at equilibrium (Kd)
were determined. The half life (t1=2) of the steroid^hMR and hGR complexes was determined from the experiments reported in Fig. 3.
Fig. 3. Dissociation of corticosteroids from hMR and hGR. hMR
and hGR were produced by translation in vitro. and incubated with
10 nM [3H]steroid for 30 min at 20‡C. The end of this incubation
period was time zero for kinetic analysis. An aliquot was kept at
20‡C to measure the stability of steroid-receptor complexes, and an
other one was incubated with 1036 M of the corresponding unla-
beled steroid. Bound and free steroids were separated by dextran-
charcoal. Non-speci¢c binding was measured in parallel incubations
for each incubation time. Results were corrected for receptor stabil-
ity and are expressed as a percentage of the binding measured at
zero time.
FEBS 23096 16-12-99
C. Hellal-Levy et al./FEBS Letters 464 (1999) 9^13 11
vation, whereas DOC, Aldo and 18OHF were very poor acti-
vators of the hGR function, even at 1036 M. B and S were
better than DOC, but 1036 M did not produce the maximal
dexamethasone-induced hGR response. 1037M F or 18oxoF
fully stimulated hGR transactivation (Fig. 4).
Thus, DOC, which has the ‘minimal’ corticosteroid struc-
ture, has a high mineralocorticoid activity and a low gluco-
corticoid activity. The 11^18 hemiketal group slightly in-
creased both mineralocorticoid and glucocorticoid activities,
whereas hydroxyl groups at position 11, 17 and 18 dramati-
cally decreased both activities. Hydroxylation at positions 11
and 17 decreased the mineralocorticoid activity, but enhanced
the glucocorticoid activity.
4. Discussion
We have identi¢ed the corticosteroid hydroxyl groups re-
sponsible for selective hormonal recognition by each class of
corticosteroid receptors.
The ¢rst step in the cascade of events that follows ligand
binding to its receptor is a change in the receptor conforma-
tion. In agreement with previous reports [20^23], ligand bind-
ing to hMR or hGR produces a receptor compaction, with an
increase in the resistance of the hMR 30 kDa fragment and
the hGR 27 and 30 kDa fragment to proteolysis. This pro-
tection was depending upon the ligand concentration and li-
gand structure. Aldosterone that dissociates more slowly from
hMR than glucocorticoids was the most e⁄cient in protecting
the receptor against proteolysis, a result in good agreement
with the observation that the unliganded receptor is more
sensitive to proteolysis than the liganded receptor. Similarly
dexamethasone, characterized by a slow o¡-rate from the
hGR, was the most e⁄cient to protect this receptor. Thus,
the steroid ability to protect the receptor against proteolysis
is depending upon its dissociation rate from the receptor.
The receptor activity was also depending upon the ligand
concentration and ligand structure. Aldosterone and dexa-
methasone, which dissociate very slowly from hMR and
hGR, respectively, are the best stimulators of the hMR and
hGR transactivation function. The order of potency of the
steroids to stabilize the receptors is the same as that to acti-
vate the receptor. Nevertheless the steroid concentrations re-
quired to ensure 50% of the maximal receptor protection
against proteolysis are higher than those necessary to induce
50% of the maximal receptor activities in transactivation as-
says, suggesting that ligand-receptor complexes might exist
under distinct conformational states. Analysis of the three
dimensional structure of the ligand-free and agonist-bound
LBD of several NRs has revealed that ligand binding induces
structural modi¢cations namely the folding back of the last
helix (H12) towards the LBD core [25]. It has been proposed
that the acquisition of a transcriptionally active conformation
is a multistep process in which an intermediate inactive com-
plex is ¢rst generated by ligand binding and then converted to
an active conformational state [22,26]. As mineralocorticoid
and glucocorticoid ligands are both able to induce a hMR and
hGR compaction, it is likely that an intermediate conforma-
tional state exists for both receptors.
The results reported here show that the stability of the
active steroid-receptor complexes is ensured by steroid-recep-
tor contacts. DOC, which has the same C21 hydroxyl group
as aldosterone and cortisol, but no substituent at C11, C17
and C18, is almost as e¡ective as aldosterone in stimulating
hMR transactivation. The contacts between hMR Asn-770
and the C21 hydroxyl group of corticosteroids, which are of
crucial importance for the hMR activation [8], are probably
su⁄cient to stabilize the active hMR conformation. The pres-
ence of one hydroxyl group at the C11 position (B) or C17 (S)
or two hydroxyl groups at the C11 and C17 positions (F) in
addition to the C21 hydroxyl group modi¢es the positioning
of the steroids within the hMR ligand binding cavity in such a
way that the steroid dissociates more rapidly from the recep-
tor, making the stabilization of the active conformation pos-
sible only with high steroid concentrations. These results are
compatible with steroid-docking studies that reveal that cor-
tisol underwent a V40‡ rotation of cortisol around its C3^
C17 axis within the hMR ligand binding pocket compared to
aldosterone [8]. The presence of three hydroxyl groups at C11,
C17 and C18 (18OHF) in addition to the C21 hydroxyl group
causes a drastic decrease in mineralocorticoid activity, that
could be due to the formation of a 18^20 hemiketal bridge
preventing the steroid contacting Cys-942, a residue involved
in the interaction with the C20 carboxyl group of mineralo-
corticoids [27]. In contrast, the presence of a 11^18 hemiketal
group alone (aldosterone) or together with a 17L-hydroxyl
group (18oxoF) increases the mineralocorticoid activity. This
result is worth noting since elevated urinary and plasma con-
centrations of 18oxoF are features of primary dexamethasone-
sensitive hyperaldosteronism [24].
The anchoring sites of the glucocorticoid hormones within
Fig. 4. Transactivation properties of hMR and hGR in response to
various corticosteroids. COS-7 cells were transiently transfected with
pchMR or pchGR, pFC31luc as reporter plasmid and a L-galactosi-
dase internal reporter to correct for transfection e⁄ciency. Cells
were treated for 24 h with corticosteroids: aldosterone (Aldo),
deoxycorticosterone (DOC), corticosterone (B), cortexolone (S), cor-
tisol (F), 18-hydroxycortisol (18OHF), 18-oxocortisol (18oxoF),
dexamethasone (Dex). hMR and hGR transactivation activities are
determined by measuring luciferase activity, normalized to the inter-
nal L-galactosidase control and expressed as percent of the receptor
activities in response to 1039M aldosterone (hMR) and 1038M
dexamethasone (hGR). Each point is the mean of three separate
experiments.
FEBS 23096 16-12-99
C. Hellal-Levy et al./FEBS Letters 464 (1999) 9^1312
the GR-LBD have not yet been identi¢ed. Nevertheless, the
common fold of the NRs [25] and the sequence similarities
suggest that the C3-ketone function of the glucocorticoid hor-
mones are anchored within the hGR-LBD by residues Gln-
570 and Arg-611 (corresponding Gln-776 and Arg-817 in the
hMR) and the C21 hydroxyl group by Asn-564, which corre-
sponds to residue Asn-770 in the hMR. We propose that the
contact between hGR and the C21 hydroxyl group of DOC,
presumably through Asn-564, does not stabilize the active
hGR conformation, and that additional contacts through
the C11 and/or C17 hydroxyl group (corticosterone, cortexo-
lone, cortisol) are necessary to enhance the stability of the
active hGR conformation.
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